Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
This report contains market size and forecasts of Vaccine for Influenza in global, including the following market information:
Global Vaccine for Influenza Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Vaccine for Influenza Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Vaccine for Influenza companies in 2021 (%)
The global Vaccine for Influenza market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Trivalent Influenza Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Vaccine for Influenza include Sanofi, CSL, GSK, Mylan, Hulan Bio, AstraZeneca and CCBIO, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Vaccine for Influenza manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Vaccine for Influenza Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Vaccine for Influenza Market Segment Percentages, by Type, 2021 (%)
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Global Vaccine for Influenza Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Vaccine for Influenza Market Segment Percentages, by Application, 2021 (%)
For Children (6 months to 3 years)
For Adults and Children over 3 years
Global Vaccine for Influenza Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Vaccine for Influenza Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Vaccine for Influenza revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Vaccine for Influenza revenues share in global market, 2021 (%)
Key companies Vaccine for Influenza sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Vaccine for Influenza sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
CSL
GSK
Mylan
Hulan Bio
AstraZeneca
CCBIO